| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7465747 |
Fluorescent label compounds |
Dec. 16, 2008 |
| 7465718 |
Ansamycins having improved pharmacological and biological properties |
Dec. 16, 2008 |
| 7459446 |
Treatment of diabetes with copper binding compounds |
Dec. 2, 2008 |
| 7456163 |
Macrocycles useful in the treatment of alzheimer's disease |
Nov. 25, 2008 |
| 7456162 |
Benzofuran derivatives, their production and use |
Nov. 25, 2008 |
| 7452861 |
Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
Nov. 18, 2008 |
| 7449453 |
Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
Nov. 11, 2008 |
| 7446102 |
Antibacterial amide macrocycles IV |
Nov. 4, 2008 |
| 7442691 |
Macrocycles useful in the treatment of alzheimer's disease |
Oct. 28, 2008 |
| 7442380 |
Treatment of diseases caused by viral infection |
Oct. 28, 2008 |
| 7435726 |
Compositions and methods for the treatment of cancer |
Oct. 14, 2008 |
| 7435408 |
Porous particles comprising excipients for deep lung delivery |
Oct. 14, 2008 |
| 7432296 |
Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
Oct. 7, 2008 |
| 7423029 |
Compounds to promote regeneration of bone marrow |
Sep. 9, 2008 |
| 7417040 |
Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 |
Aug. 26, 2008 |
| 7417039 |
Use of substituted azetidinone compounds for the treatment of sitosterolemia |
Aug. 26, 2008 |
| 7414065 |
Methods to modulate conditions mediated by the CXCR4 receptor |
Aug. 19, 2008 |
| 7407987 |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
Aug. 5, 2008 |
| 7407948 |
Photosensitisers and their uses |
Aug. 5, 2008 |
| 7405208 |
Benzoquinone ansamycins |
Jul. 29, 2008 |
| 7402262 |
Electroconductive polymers |
Jul. 22, 2008 |
| 7396828 |
PI-3 kinase inhibitor prodrugs |
Jul. 8, 2008 |
| RE40418 |
Treatment of neoplasms with CCI-779/EKB-569 combination |
Jul. 1, 2008 |
| RE40387 |
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
Jun. 17, 2008 |
| 7388029 |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
Jun. 17, 2008 |
| 7384942 |
Pyrazine based inhibitors of glycogen synthase kinase 3 |
Jun. 10, 2008 |
| 7378407 |
Geldanamycin compounds and method of use |
May. 27, 2008 |
| 7368443 |
2,6-disubstituted piperidines and piperazine compounds |
May. 6, 2008 |
| 7361687 |
Arylsulphonamide derivatives and methods of preparing |
Apr. 22, 2008 |
| 7361647 |
Analogs of benzoquinone-containing ansamycins and methods of use thereof |
Apr. 22, 2008 |
| 7347984 |
Mammalian agmatinase inhibitory substance |
Mar. 25, 2008 |
| 7345020 |
Mimetics of CD4 that inhibit immune response |
Mar. 18, 2008 |
| 7341744 |
Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer |
Mar. 11, 2008 |
| 7338945 |
Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino-2-cyclopentenyl-1- -methanol |
Mar. 4, 2008 |
| 7335645 |
Effectors of dipeptidyl peptidase IV for topical use |
Feb. 26, 2008 |
| 7332149 |
Vitronectin receptor antagonist pharmaceuticals |
Feb. 19, 2008 |
| 7329651 |
Cannabimimetic ligands |
Feb. 12, 2008 |
| 7326421 |
Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues |
Feb. 5, 2008 |
| 7323195 |
Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
Jan. 29, 2008 |
| 7320960 |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
Jan. 22, 2008 |
| 7312237 |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
Dec. 25, 2007 |
| 7309699 |
3-Quinuclidinyl amino-substituted biaryl derivatives |
Dec. 18, 2007 |
| 7307071 |
RAF-MEK-ERK pathway inhibitors to treat cancer |
Dec. 11, 2007 |
| 7297689 |
Method for preparing peritoneal dialysate |
Nov. 20, 2007 |
| 7282493 |
Analogs of benzoquinone-containing ansamycins and methods of use thereof |
Oct. 16, 2007 |
| 7276514 |
Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
Oct. 2, 2007 |
| 7276493 |
Fungicide for treating plants |
Oct. 2, 2007 |
| 7273872 |
Inhibition of inflammation using .alpha. 7 receptor-binding cholinergic agonists |
Sep. 25, 2007 |
| 7273857 |
Benzimidazolidinone derivatives as muscarinic agents |
Sep. 25, 2007 |
| 7271160 |
Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases |
Sep. 18, 2007 |
|
|
|
